Updates on the risk factors for latent tuberculosis reactivation and their managements

Jing-Wen AiDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai200040, China

Qiao-Ling RuanDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai200040, China

Qi-Hui LiuDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai200040, China

Wen-Hong ZhangDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai200040, ChinaCorrespondence[email protected]

Pages 1-8 | Received 10 Sep 2014, Accepted 23 Nov 2015, Published online: 25 Jan 2019

Cite this article
https://doi.org/10.1038/emi.2016.10
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

World Health Organization. Global Tuberculosis Report 2015. Geneva: WHO, 2015. Available at http://www.who.int/tb/publications/global_report/en/(accessed 23 November 2015).
Google Scholar
RoseDN,SchecterCB,AdlerJJ .Interpretation of the tuberculin skin test.J Gen Intern Med1995; 10:635–642.
PubMed Web of Science ®Google Scholar
ParekhMJ,SchlugerNW .Treatment of latent tuberculosis infection.Ther Adv Respir Dis2013; 7:351–356.
PubMed Web of Science ®Google Scholar
LandryJ,MenziesD .Preventive chemotherapy. Where has it got us? Where to go next?Int J Tuberc Lung Dis2008; 12:1352–1364.
PubMed Web of Science ®Google Scholar
MenziesD,PaiM,ComstockG .Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.Ann Intern Med2007; 146:340–354.
PubMed Web of Science ®Google Scholar
PaiM,RileyLW,ColfordJMJr .Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.Lancet Infect Dis2004; 4:761–776.
PubMed Web of Science ®Google Scholar
CattamanchiA,SmithR,SteingartKRet al.Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis.J Acquir Immune Defic Syndr2011; 56:230–238.
PubMed Web of Science ®Google Scholar
Linas BP,Wong AY,Freedberg KA.Priorities for screening and treatment of latent tuberculosis infection in the United States.Am J Respir Crit Care Med2011; 184:590–596.
PubMed Web of Science ®Google Scholar
HorsburghCR,RubinsEJ.Latent tuberculosis infection in the United States.N Engl J Med2011; 364:1441–1448.
PubMed Web of Science ®Google Scholar
American Thoracic Society.Targeted tuberculin testing and treatment of latent tuberculosis infection.MMWR Recomm Rep2000; 49:1–51.
Google Scholar
RangakaMX,WilkinsonKA,GlynnJRet al.Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis.Lancet Infect Dis2012; 12:45–55.
PubMed Web of Science ®Google Scholar
MetcalfeJZ,EverettCK,SteingartKRet al.Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis.J Infect Dis2011; 204:S1120–S1129.
PubMed Web of Science ®Google Scholar
WatkinsRE,BrennanR,PlantAJ .Tuberculin reactivity and the risk of tuberculosis: a review.Int J Tuberc Lung Dis2000; 4:895–903.
PubMed Web of Science ®Google Scholar
World Health Organization.Global tuberculosis control: a short update to the 2009 Report.Geneva:WHO,2010.http://www.who.int/tb/features_archive/globalreport09_update_8dec09/en/ (accessed 9 September 2015).
Google Scholar
SutherlandI .Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli.Adv Tuberc Res1976; 19:1–63.
PubMedGoogle Scholar
AguadoJM,HerreroJA,GavaldaJet al.Clinical presentation and outcome of tuberculosis in kidney, liver and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.Transplantation1997; 63:1278–1286.
PubMed Web of Science ®Google Scholar
SakhujaV,JhaV,VarmaPPet al.The high incidence of tuberculosis among renal transplant recipients in India.Transplantation1996; 61:211–215.
PubMed Web of Science ®Google Scholar
AndrewOT,SchoenfeldPY,HopewellPCet al.Tuberculosis in patients with end-stage renal disease.Am J Med1980; 68:59–65.
PubMed Web of Science ®Google Scholar
LundinAP,AdlerAJ,BerlyneGMet al.Tuberculosis in patients undergoing maintenance hemodialysis.Am J Med1979; 67:597–602.
PubMed Web of Science ®Google Scholar
BelconMC,SmithEK,KahanaLMet al.Tuberculosis in dialysis patients.Clin Nephrol 1982; 17:14–18.
PubMed Web of Science ®Google Scholar
HusseinMM,MooijJM,RoujoulehH .Tuberculosis and chronic renal disease.Semin Dial2003; 16:38–44.
PubMed Web of Science ®Google Scholar
SolovicI,SesterM,Gomez-ReinoJJet al.The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET Consensus Statement.Eur Respir J2010; 36:1185–1206.
PubMed Web of Science ®Google Scholar
CowieRL .The epidemiology of tuberculosis in gold miners with silicosis.Am J Respir Crit Care Med1994; 150:1460–1462.
PubMed Web of Science ®Google Scholar
GrzybowskiS,FishautH,RoweJet al.Tuberculosis among patients with various radiologic abnormalities, followed by the chest clinic service.Am Rev Respir Dis1971; 104:605–608.
PubMed Web of Science ®Google Scholar
BaussanoI,MercadanteS,PareekMet al.High rates of Mycobacterium tuberculosis among socially marginalized immigrants in low-incidence area, 1991–2010, Italy.Emerg Infect Dis2013; 19:1437–1445.
PubMed Web of Science ®Google Scholar
ChuH,ShihCJ,LeeYJet al.Risk of tuberculosis among healthcare workers in an intermediate-burden country: a nationwide population study.J Infect2014; 69:525–532.
PubMed Web of Science ®Google Scholar
HarriesAD,LinY,SatyanarayanaSet al.The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis.Int J Tuberc Lung Dis2011; 15:1436–1444.
PubMed Web of Science ®Google Scholar
DoblerCC,FlackJR,MarksGB .Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study.BMJ Open2012; 2:e000666.
PubMed Web of Science ®Google Scholar
JeonCY,MurrayMB .Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.PLoS Med2008; 5:e152.
PubMed Web of Science ®Google Scholar
BoucotKR .Diabetes mellitus and pulmonary tuberculosis.J Chronic Dis1957; 6:256–279.
PubMedGoogle Scholar
KimSJ,HongYP,LewWJet al.Incidence of pulmonary tuberculosis among diabetics.Tubercle Lung Dis1995; 76:529–533.
PubMedGoogle Scholar
BakerMA,LinHH,ChangHYet al.The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study.Clin Infect Dis2012; 54:818–825.
PubMed Web of Science ®Google Scholar
AltetMN,AlcaideJ,PlansPet al.Passive smoking and risk of pulmonary tuberculosis in children immediately following infection. A case control study.Tubercle Lung Dis1996; 77:537–544.
PubMedGoogle Scholar
SlamaK,ChiangCY,EnarsonDAet al.Tobacco and tuberculosis: a qualitative systematic review and meta- analysis.Int J Tuberc Lung Dis2007; 11:1049–1061.
PubMed Web of Science ®Google Scholar
MauryaV,VijayanVK,ShahA .Smoking and tuberculosis: an association overlooked.Int J Tuberc Lung Dis2002; 6:942–951.
PubMed Web of Science ®Google Scholar
JickSS,LiebermanES,RahmanMUet al.Glucocorticoid use, other associated factors, and the risk of tuberculosis.Arthritis Rheum2006; 55:19–26.
PubMed Web of Science ®Google Scholar
PalmerCE,JablonS,EdwardsPQ .Tuberculosis morbidity of young men in relation to tuberculin sensitivity and body build.Am Rev Tuberc1957; 76:517–539.
PubMedGoogle Scholar
ComstockGW .Frost revisited: the modern epidemiology of tuberculosis.Am J Epidemiol1975; 101:363–382.
PubMed Web of Science ®Google Scholar
AkoloC,AdetifaI,ShepperdSet al.Treatment of latent tuberculosis infection in HIV Infected Persons.Cochrane Database Syst Rev2010; CD000171. doi: 10.1002/14651858.
PubMed Web of Science ®Google Scholar
World Health Organization.Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: WHO, 2011.Available at http://www.who.int/HIV/pub/tb/9789241500708/en/ (accessed 17 October 2015).
Google Scholar
World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva: WHO, 2015.Available at http://www.who.int/tb/publications/ltbi_document_page/en/ (accessed 23 October 2015).
Google Scholar
LloverasJ,PetersonPK,SimmonsRLet al.Mycobacterial infections in renal transplant patients.Arch Intern Med1982; 142:888–892.
PubMedGoogle Scholar
LichtensteinIH,MacGregorRR .Mycobacterial infections in renal transplant patients: report of 5 cases and review of literature.Rev Infect Dis1983; 5:216–226.
PubMedGoogle Scholar
Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong.Am Rev Respir Dis1992; 145:36–41.
PubMed Web of Science ®Google Scholar
MainiR,St ClairEW,BreedveldFet al.Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.Lancet1999; 354:1932–1939.
PubMed Web of Science ®Google Scholar
KeaneJ,GershonS,WiseRPet al.Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.N Engl J Med2001; 345:1098–1104.
PubMed Web of Science ®Google Scholar
FonsecaJE,CanhaoH,SilvaCet al.Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience.Acta Reumatol Port2006; 31:247–253.
PubMedGoogle Scholar
BrassardP,KezouhA,SuissaS .Antirheumatic drugs and the risk of tuberculosis.Clin Infect Dis2006; 43:717–722.
PubMed Web of Science ®Google Scholar
AiJW,ZhangS,RuanQLet al.The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry/Cohort Studies.J Rheumatol2015 Dec; 42:2229–2237. doi: 10.3899/jrheum.150057.
PubMed Web of Science ®Google Scholar
British Thoracic Society Standards of Care Committee, Joint Tuberculosis Committee, Milburn H, et al.Guidelines for prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease.Thorax2010; 65:557–570.
PubMed Web of Science ®Google Scholar
Prevention Committee of the Japanese Society for Tuberculosis, Treatment Committee of the Japanese Society for Tuberculosis.Treatment Guidelines for Latent Tuberculosis Infection.Kekkaku2014; 89:21–37.
PubMedGoogle Scholar
CengizK .Should tuberculosis prophylaxis be given to chronically dialyzed patients?Nephron2000; 86:411–413.
PubMed Web of Science ®Google Scholar
International Union Against Tuberculosis Committee on prophylaxis.Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial.Bull World Health Organ1982; 60:555–564.
PubMed Web of Science ®Google Scholar
HorsburghCR,GoldbergS,BethelJet al.Tuberculosis Epidemiologic Studies Consortium. Latent tuberculosis infection treatment acceptance and completion in 2002 in the United States and Canada.Chest2010; 137:401–409.
PubMed Web of Science ®Google Scholar
BlumRN,PolishLB,TapyJMet al.Results of screening for tuberculosis in foreign-born persons applying for adjustment of immigration status.Chest1993; 103:1670–1674.
PubMed Web of Science ®Google Scholar
CainKP,BenoitSR,WinstonCAet al.Tuberculosis among foreign-born persons in the United States.JAMA2008; 300:405–412.
PubMed Web of Science ®Google Scholar
PareekM,BaussanoI,AbudakarIet al.Evaluation of immigrant.Emerg Infect Dis2012; 18:1422–1429.
PubMed Web of Science ®Google Scholar
KikSV,FrankenWP,MensenMet al.Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts.Eur Respir J2010; 35:1346–1353.
PubMed Web of Science ®Google Scholar
PareekM,BondM,ShoreyJet al.Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis.Thorax2013; 68:230–239.
PubMed Web of Science ®Google Scholar
National Institute for Health and Clinical Excellence: NICE clinical guideline 117. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London ,2011.
Google Scholar
HernándezM,CasarC,GarcíaJet al.Latent tuberculosis infection screening in healthcare workers in four large hospitals in Santiago, Chile.Rev Chilena Infectol2014; 31:254–260.
PubMed Web of Science ®Google Scholar
CatanzaroA .Nosocomial tuberculosis.Am Rev Respir Dis1982; 125:559–562.
PubMed Web of Science ®Google Scholar
MalaskyC,JordanT,PotulskiFet al.Occupational tuberculosis infections among pulmonary physicians in training.Am Rev Respir Dis1990; 142:505–507.
PubMed Web of Science ®Google Scholar
NardellEA .Dodging droplet nuclei: reducing the probability of nosocomial tuberculosis transmission in the AIDS era.Am Rev Respir Dis1990; 140:501–503.
Web of Science ®Google Scholar
SteadWW .Annual tuberculosis screening of hospital employees-an idea whose time has not passed (Editorial).Am Rev Respir Dis1987; 136:803–804.
PubMed Web of Science ®Google Scholar
GrahamNM,NelsonKE,SolomonLet al.Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.JAMA1992; 267:369–372.
PubMed Web of Science ®Google Scholar
ZolopaAR,HahnJA,GorterRet al.HIV and tuberculosis infection in San Francisco’s homeless adults.JAMA1994; 272:455–461.
PubMed Web of Science ®Google Scholar
WallaceR,WallaceD .Community marginalization and the diffusion of disease and disorder in the United States.BMJ1997; 314:1341–1345.
PubMed Web of Science ®Google Scholar
AndersonC,StoryA,BrownTet al.Tuberculosis in UK prisoners: a challenge for control.J Epidemiol Community Health2010; 64:373–376.
PubMed Web of Science ®Google Scholar
LeungCC,LamTH,ChanWMet al.Diabetic control and risk of tuberculosis: a cohort study.Am J Epidemiol2008; 167:1486–1494.
PubMed Web of Science ®Google Scholar
ChanED,KinneyWH,HondaJRet al.Tobacco exposure and susceptibility to tuberculosis: is there a smoking gun?Tuberculosis2014; 94:544–550.
PubMed Web of Science ®Google Scholar
ChanED,KeaneJ,IsemanMD .Should cigarette smoke exposure be a criterion to treat latent tuberculous infection?Am J Respir Crit Care Med2010; 182:990–992.
PubMed Web of Science ®Google Scholar
van Zyl SmitRN,PaiM,YewWWet al.Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD.Eur Respir J2010; 35:27–33.
PubMed Web of Science ®Google Scholar
EgsmoseT,Ang’awaJO,PotiSJ .The use of isoniazid among household contacts of open cases of pulmonary tuberculosis.Bull World Health Organ1965; 33:419–433.
PubMed Web of Science ®Google Scholar
ComstockGW .How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?Int J Tuberc Lung Dis1999; 3:847–850.
PubMed Web of Science ®Google Scholar
ChurchyardGJ,FieldingKL,LewisJJet al.A trial of mass isoniazid preventive therapy for tuberculosis control.N Engl J Med2014; 370:301–310.
PubMed Web of Science ®Google Scholar
MenziesD,DionMJ,RabinovitchBet al.Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months.Am J Respir Crit Care Med2004; 170:445–449.
PubMed Web of Science ®Google Scholar
MenziesD,LongR,TrajmanAet al.Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial.Ann Intern Med2008; 149:689–697.
PubMed Web of Science ®Google Scholar
HollandDP,SandersGD,HamiltonCDet al.Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.Am J Respir Crit Care Med2009; 179:1055–1060.
PubMed Web of Science ®Google Scholar
Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: code of practice 2000.Thorax2000; 55:887–901.
PubMed Web of Science ®Google Scholar
SterlingTR,VillarinoME,BorisovASet al.Three months of rifapentine and isoniazid for latent tuberculosis infection.N Engl J Med2011; 365:2155–2166.
PubMed Web of Science ®Google Scholar
SterlingTR,MoroRN,BorisovASet al.Flu-like and other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid or daily isoniazid for treatment of latent tuberculosis infection in the PREVENT tuberculosis study.Clin Infect Dis2015; 61:527–535.
PubMed Web of Science ®Google Scholar
GordinF,ChaissonRE,MattsJPet al.Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on Aids, the Adult Aids Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.JAMA2000; 283:1445–1450.
PubMed Web of Science ®Google Scholar
HalseyNA,CoberlyJS,DesormeauxJet al.Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.Lancet1998; 351:786–792.
PubMed Web of Science ®Google Scholar
From the Centers for Disease Control and Prevention. Fatal and Severe Hepatitis Associated with Rifampin and Pyrazinamide for the Treatment of Latent Tuberculosis Infection–New York and Georgia, 2000.JAMA2001; 285:2572–2573.
PubMed Web of Science ®Google Scholar
From the Centers for Disease Control and Prevention .Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations–United States, 2001.JAMA2001; 286:1445–1446.
PubMed Web of Science ®Google Scholar
Centers for Disease Control and Prevention, American Thoracic Society.Update: adverse event data and revised. American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection–United States, 2003.MMWR Morb Mortal Wkly Rep2003; 52:735–739.
PubMedGoogle Scholar
PapeJW,JeanSS,HoJLet al.Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection.Lancet1993; 342:268–272.
PubMed Web of Science ®Google Scholar
GrantAD,CharalambousS,FieldingKLet al.Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.JAMA2005; 293:2719–2725.
PubMed Web of Science ®Google Scholar
WhalenCC,JohnsonJL,OkweraAet al.A trial of three regimens to prevent tuberculosis in ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.N Engl J Med1997; 337:801–808.
PubMed Web of Science ®Google Scholar
RangakaMX,WilkinsonRJ,BoulleAet al.Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.Lancet2014; 384:682–690.
PubMed Web of Science ®Google Scholar
BucherHC,GriffithLE,GuyattGHet al.Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials.AIDS1999; 13:501–507.
PubMed Web of Science ®Google Scholar
SamandariT,AgizewTB,NyirendaSet al.6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.Lancet2011; 377:1588–1598.
PubMed Web of Science ®Google Scholar
MartinsonNA,BarnesGL,MoultonLHet al.New regimens to prevent tuberculosis in adults with HIV infection.N Engl J Med2011; 365:11–20.
PubMed Web of Science ®Google Scholar
JohnGT,ThomasPP,ThomasMet al.A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients.Transplantation1994; 57:1683–1684.
PubMed Web of Science ®Google Scholar
NaqviR,NaqviA,AkhtarSet al.Use of isoniazid chemoprophylaxis in renal transplant recipients.Nephrol Dial Transplant2010; 25:634–637.
PubMed Web of Science ®Google Scholar
de LemosAS,VieiraMA,HalpernMet al.Results of implementation of preventive recommendations for tuberculosis after renal transplantation in an endemic area.Am J Transplant2013; 13:3230–3235.
PubMed Web of Science ®Google Scholar
CurrieAC,KnightSR,MorrisPJ .Tuberculosis in renal transplant recipients: the evidence for prophylaxis.Transplantation2010; 90:695–704.
PubMed Web of Science ®Google Scholar
SichletidisL,SettasL,SpyratosDet al.Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.Int J Tuberc Lung Dis2006; 10:1127–1132.
PubMed Web of Science ®Google Scholar
SeongSS,ChoiCB,WooJHet al.Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.J Rheumatol2007; 34:706–711.
PubMed Web of Science ®Google Scholar
Gomez-ReinoJJ,CarmonaL,Angel DescalzoMet al.Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.Arthritis Rheum2007; 57:756–761.
PubMed Web of Science ®Google Scholar
TamLS,LeungCC,YingSKet al.Risk of tuberculosis in patients with rheumatoid arthritis in Hong Kong–the role of TNF blockers in an area of high tuberculosis burden.Clin Exp Rheumatol2010; 28:679–685.
PubMed Web of Science ®Google Scholar
van der WerfMJ,LangendamMW,SandgrenAet al.Lack of evidence to support policy development for management of contacts of multidrug-resistant tuberculosis patients: two systematic reviews.Int J Tuberc Lung Dis2012; 16:288–296.
PubMed Web of Science ®Google Scholar
FraserA,PaulM,AttamnaAet al.Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis.Cochrane Database Syst Rev2006; 2:CD005435.
Google Scholar
BamrahS,BrostromR,DorinaFet al.Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009–2012.Int J Tuberc Lung Dis2014; 18:912–918.
PubMed Web of Science ®Google Scholar
VikrantS,AgarwalSK,GuptaSet al.Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.Transpl Infect Dis2005; 7:99–108.
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Updates on the risk factors for latent tuberculosis reactivation and their managements

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Updates on the risk factors for latent tuberculosis reactivation and their managements

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date